Toshiba and IBA: partners in proton and carbon particle therapy

Pairing proton therapy with carbon therapy — two cutting edge approaches to particle therapy — Toshiba Medical Systems Corporation and IBA have formed a powerful union. This strategic alliance will allow Toshiba to be the distributor of IBA’s ProteusONE in the company’s native Japan, meanwhile IBA — a Belgium-based leader in proton therapy — will become the agent for Toshiba’s carbon therapy solutions in international regions outside of Japan.

DotMed News